Diabetes Drug Actos Bladder Cancer Lawsuits
The diabetes drug Actos is now known to cause bladder cancer. Anyone who has taken Actos and then developed bladder cancer should consider an Actos lawsuit against the drug's manufacturer. Bladder cancer is a side effect of all drugs in the "Actos family," including Duetact, ActoPlus Met, and ActoPlus Met RX.
Actos Bladder Cancer Side Effect
Actos was on the market for over a decade before the public learned that bladder cancer is an Actos side effect. In 1999, the FDA approved Actos, generic name name pioglitazone, as a treatment for type II diabetes. It is not used for patients with type I ("juvenile") diabetes or diabetic ketoacidosis. The usual dose is 15 or 30 milligrams (mg) once a day. Actos is manufactured by the Japanese company Takeda Pharmaceuticals.
FDA Actos Bladder Cancer Side Effect Warnings
On September 17, 2010, the FDA notified healthcare professionals and patients that the agency was reviewing data from an ongoing ten-year epidemiological study designed to evaluate the risk of bladder cancer from Actos use. On June 15, 2011, the FDA announced that based on their review of the study, there is an increased risk of bladder cancer when Actos is used for more than one year. On August 4, 2011, the FDA announced that Actos must contain a warning that its use for more than one year is associated with bladder cancer.
Bladder Cancer Side Effect Leads Other Countries to Ban Actos
Several European nations are taking the Actos bladder cancer risk more seriously than the United States. Both France and Germany have completely banned the sale of Actos due to the bladder cancer side effect.
On June 6, 2011, the French Health Products Safety Agency (AFSSAPS) announced that effective July 11, 2011, Actos would be removed from the market in France. The French agency gave advance notice of the ban so patients taking Actos could consult with their physicians regarding alternate diabetes treatments. The agency banned the sale of Actos based on a French study showing that those who received a cumulative dose of 28,000 mg or more of Actos had an increased risk of bladder cancer. Based on this same study, Germany has also banned Actos.
Actos Bladder Cancer Lawsuits
If you or someone you love has developed bladder cancer after taking Actos, you may have a legal claim against the manufacturer of Actos. DeCarli Law is among the first law firms in the country to investigate and litigate Actos bladder cancer claims. Contact DeCarli Law for a free, no obligation consultation with an attorney to learn your legal rights and options.